Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | DRD1 | P21728 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 4/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.31 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49858 | 0.95 | CYP3A4 (0.52) | CYP3A4TDP1DRD1ACHETSHR | |
| Bromide SCHEMBL30317742 | 0.93 | CYP3A4 (0.50) | CYP3A4TDP1DRD1ACHETSHR | |
| SCHEMBL3717033 | 0.93 | CYP3A4 (0.57) | CYP3A4TDP1DRD1ACHETSHR | |
| Hydrochloric Acid SCHEMBL11571801 | 0.93 | CYP3A4 (0.50) | CYP3A4TDP1DRD1ACHETSHR | |
| SCHEMBL31532278 | 0.93 | CYP3A4 (0.50) | CYP3A4TDP1DRD1ACHETSHR | |
| SCHEMBL31531976 | 0.93 | CYP3A4 (0.50) | CYP3A4TDP1DRD1ACHETSHR | |
| Hydrochloric Acid SCHEMBL31198728 | 0.93 | CYP3A4 (0.50) | CYP3A4TDP1DRD1ACHETSHR | |
| Iodide SCHEMBL30903480 | 0.93 | CYP3A4 (0.50) | CYP3A4TDP1DRD1ACHETSHR | |
| Iodide SCHEMBL31531977 | 0.91 | CYP3A4 (0.48) | CYP3A4TDP1DRD1ACHETSHR | |
| SCHEMBL29535212 | 0.91 | CYP3A4 (0.52) | CYP3A4TDP1DRD1ACHETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150105571-A1 | METHOD FOR CONVERTING CARBON DIOXIDE AND BICARBONATES INTO FORMIC ACID DERIVATIVES USING A COBALT COMPLEX AS A CATALYTIC SYSTEM | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2015-04-16 | — | — | US | disclosed |
| US-20140255296-A1 | METHOD FOR OBTAINING HYDROGEN BY CATALYTIC DECOMPOSITION OF FORMIC ACID | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105571-A1 | METHOD FOR CONVERTING CARBON DIOXIDE AND BICARBONATES INTO FORMIC ACID DERIVATIVES USING A COBALT COMPLEX AS A CATALYTIC SYSTEM | CA3, CA2, CA1 | CYP3A4 356/4885TDP1 3664/4885DRD1 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.